Novartis has broken ground on a $280 million, 20-acre radioligand therapy manufacturing facility in Denton, Texas.
Novartis has officially broken ground on a new radioligand therapy manufacturing facility in Denton, Texas, located at 2101 Shady Oaks Drive. The 20-acre site, which has been nonoperational since 2009, will serve as the company's fifth U.S. location dedicated to the specialized cancer treatment. The project is expected to be operational by 2028 and is part of a broader $23 billion U.S. investment by the Swiss pharmaceutical company.
The development is supported by more than $3 million in local incentives and a 10-year state property tax exemption valued at approximately $5.9 million. The facility is projected to create at least 150 jobs, with an average salary exceeding $124,000, focusing on high-tech manufacturing roles.
Tesla executives confirm that the next-generation Roadster will be produced at the Gigafactory Texas facility located east of Austin.
Sunbelt Rentals plans to expand its Grapevine site by 5.13 acres to increase heavy machinery and equipment storage capacity.
Aeon Industrial plans an $8.5 million, 48,000-square-foot headquarters and manufacturing facility in Cedar Park, creating at least 135 new jobs.
Daily emails covering the projects and news that match your service area, building types, and the project stages you bid on.
Free now — first 50 founding members lock in 30% off at launch.
Free. One click to unsubscribe. No tracking pixels.